The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence.

[1]  C. Benoist,et al.  Monoclonal antibodies to NF‐Y define its function in MHC class II and albumin gene transcription. , 1992, The EMBO journal.

[2]  W. Reith,et al.  The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters , 1992, Molecular and cellular biology.

[3]  G. Nepom,et al.  Differential expression of related HLA class II DQ beta genes caused by nucleotide variation in transcriptional regulatory elements. , 1992, Journal of immunology.

[4]  Santa Jeremy Ono,et al.  Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Santa Jeremy Ono,et al.  Transcription of a subset of human class II major histocompatibility complex genes is regulated by a nucleoprotein complex that contains c-fos or an antigenically related protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Ting,et al.  Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function , 1991, Molecular and cellular biology.

[7]  W. Reith,et al.  Regulatory factor-X binding to mutant HLA-DRA promoter sequences. , 1991, Nucleic acids research.

[8]  G. Nepom,et al.  Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes , 1991, The Journal of experimental medicine.

[9]  B. Peterlin,et al.  NF-X2 that binds to the DRA X2-box is activator protein 1. Expression cloning of c-Jun. , 1990, Journal of immunology.

[10]  C. Benoist,et al.  Co‐evolution from yeast to mouse: cDNA cloning of the two NF‐Y (CP‐1/CBF) subunits. , 1990, The EMBO journal.

[11]  W. Reith,et al.  MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain. , 1990, Genes & development.

[12]  R. O’Hehir,et al.  Direct evidence for a functional role of HLA-DRB1 and -DRB3 gene products in the recognition of Dermatophagoides spp. (house dust mite) by helper T lymphocytes. , 1990, International immunology.

[13]  I. Verma,et al.  mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element , 1990, Molecular and cellular biology.

[14]  N. Zeleznik-Le,et al.  A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. , 1990, Science.

[15]  M. Kasahara,et al.  Evolution of the Class II Major Histocompatibility Complex Alleles in Higher Primates , 1990, Immunological reviews.

[16]  J. Gorski.  HLA-DR beta-chain polymorphism. Second domain polymorphism reflects evolutionary relatedness of alleles and may explain public serologic epitopes. , 1989, Journal of immunology.

[17]  W. Reith,et al.  Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Marrack,et al.  Influence of the major histocompatibility complex on positive thymic selection of V beta 17a+ T cells. , 1989, Science.

[19]  H. Harris,et al.  Expression of a human placental alkaline phosphatase gene in transfected cells: use as a reporter for studies of gene expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. Reith,et al.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X , 1988, Cell.

[21]  B. Mach,et al.  Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones , 1988, The Journal of experimental medicine.

[22]  C. Benoist,et al.  A multiplicity of CCAAT box-binding proteins , 1987, Cell.

[23]  B. Mach,et al.  Constitutive and induced expression of the individual HLA-DR beta and alpha chain loci in different cell types. , 1987, Journal of immunology.

[24]  B. Luckow,et al.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements , 1987, Nucleic Acids Res..

[25]  P. Marrack,et al.  T cell tolerance by clonal elimination in the thymus , 1987, Cell.

[26]  R. Germain.  Immunology: The ins and outs of antigen processing and presentations , 1986, Nature.

[27]  B. Mach,et al.  Linkage map of three HLA-DR beta-chain genes: evidence for a recent duplication event. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. A. Peterson,et al.  HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. , 1985, Journal of immunology.

[29]  C. Rabourdin-Combe,et al.  Serological and immunochemical analysis of the products of a single HLA DR-alpha and DR-beta chain gene expressed in a mouse cell line after DNA-mediated cotransformation reveals that the beta chain carries a known supertypic specificity , 1985, The Journal of experimental medicine.

[30]  C. Janeway,et al.  Quantitative variation in la antigen expression plays a central role in immune regulation. , 1984, Immunology today.

[31]  D. Boraschi,et al.  Changes underway in Italy. , 1984, Immunology today.

[32]  W. Paul,et al.  Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[34]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Meador,et al.  Polymorphism in the promoter region of HLA-DRB genes. , 1993, Human immunology.

[36]  L. Glimcher,et al.  Sequences and factors: a guide to MHC class-II transcription. , 1992, Annual review of immunology.

[37]  C. Benoist,et al.  Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. , 1990 .

[38]  P. Sharp,et al.  A high-efficiency HeLa cell nuclear transcription extract. , 1988, DNA.

[39]  R. Bontrop,et al.  Quantitative and qualitative differences in HLA‐DR molecules correlated with antigen‐presentation capacity , 1986, European journal of immunology.

[40]  C. Ucla,et al.  Polymorphism and regulation of HLA class II genes of the major histocompatibility complex. , 1986, Cold Spring Harbor symposia on quantitative biology.